Artrya’s coronary diagnostic product has been given regulatory approval for use in the UK after being knocked back by the US Food and Drug Administration five months ago.
Construction is expected to start this year on the WA segment of the $3 billion Square Kilometre Array radio telescope, which was today given a traditional name from the Wajarri Yamaji people.
It might have seemed like a battle between resources efficiency and digital health and wellbeing but the winner of this year’s Curtinnovation awards was from the traditional world of medical research – a possible cause of Alzheimer’s disease.
Researchers Steve Wilton and Sue Fletcher have been recognised for their biotech industry leadership, while a life science legacy award has been presented to Andrew and Nicola Forrest.
Robotic technology company FBR has announced a $20 million capital raising that marks the first major ECM deal for investment bank Jarden in Western Australia.
Perth-based acQuire Technology Solutions has expanded its suite of information management tools for the resources sector with the acquisiton of South African company MTS.
The nation’s peak body for directors has apologised to its members after being forced to shut down an online cyber security seminar amid fears it had been infiltrated by hackers.
Perth-based gaming company VGW Holdings has confirmed it is likely to pursue an IPO in North America after reporting another spectacular lift in annual profit to $454 million.
Diversified miner and contractor Mineral Resources has extended its support for the Harry Perkins Institute of Medical Research, taking its total contribution to $2.25 million.
The Wajarri Yamaji community has voted to approve a land use agreement to build the world’s largest radio telescope in the Murchison, a big step towards starting construction.
The company behind Marian Sturm’s life-changing cellular treatment has failed in its bid to have the state health department’s lawsuit against it thrown out, as the ownership battle continues.
Startups will have access to reams of information on early-stage innovation courtesy of a European database paid for by the state government's new industry fund.
The boss of Clough family-backed NeuroScientific Biopharmaceuticals has resigned just days after the national research ethics body refused a trial for its Alzheimer’s treatment.
Shares in Clough family-backed NeuroScientific Biopharmaceuticals have plunged after a planned clinical trial for its budding Alzheimer’s treatment was rejected by the Human Research Ethics Committee.
West Perth company Avicena Systems has ticked off another big achievement, with the Therapeutic Goods Administration authorising its locally developed diagnostic technology.